NCT06496724View on ClinicalTrials.gov

A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

July 1, 2025

Conditions
Breast Cancer
Interventions
BIOLOGICAL

Albumin paclitaxel/neutrophil drug

Isolate the patients' autologous neutriphil cells, induce and culture them with albumin paclitaxel in vitro. The final product for Albumin paclitaxel/neutrophil drug.

Trial Locations (2)

210002

RECRUITING

Jinling Hospital, Nanjing

RECRUITING

Jinling Hospital, Nanjing

Sponsors
All Listed Sponsors
collaborator

China Pharmaceutical University

UNKNOWN

lead

JIANG LONGWEI

OTHER